ABM price target lowered to $45 from $47 at Truist

Truist lowered the firm’s price target on ABM (ABM) to $45 from $47 and keeps a Hold rating on the shares. The stock underperformed after a Q1 margin miss, and the company’s results made its FY26 outlook more second-half weighted, with an expectation for project activity to improve sequentially, the analyst tells investors in a research note. Truist adds however that the stock is “increasingly cheap” on a free cash flow basis.